EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Global Hemostasis Testing in Chronic Kidney Disease—Are They Better Predictors of Bleeding and Thrombosis Risk?

Hui Yin Lim iD, Eng Soo Yap, Prahlad Ho

Seminars in Thrombosis and Hemostasis · 01.06.2026 · 52 (04) · 391-404

DOI: 10.1055/s-0045-1809162 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.06.2026. Verfasst von Hui Yin Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Northern Clinical Diagnostics and Thrombovascular Research (NECTAR), Northern Health, Epping, Victoria, Australia. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Thrombosis, Hemostasis, Hemorrhage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) affects over 10% of the global population and significantly increases the risk of cardiovascular disease as well as arising bleeding. There are alterations in hemostasis, which are multifactorial, involving complex interactions between coagulation, platelets, and the vessel wall. Hemostasis evaluation in CKD is critical for the optimal management of patients. However, conventional coagulation testing and renal function do not fully reflect the hemostatic alterations and do not adequately represent the risk of bleeding and/or thrombosis in patients with CKD. Global hemostatic assays, including thrombin and fibrin generation assays, provide a more wholesome assessment of the process, including the interaction between procoagulants, anticoagulants, platelets, and fibrinolysis. This review critically appraises published studies reporting the use of global coagulation assays to evaluate hemostasis in patients with CKD, as well as associated clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicThrombosisHemostasisHemorrhageHumansRisk FactorsBlood Coagulation Tests

Autor:innen und Institutionen

  • Northern Clinical Diagnostics and Thrombovascular Research (NECTAR), Northern Health, Epping, Victoria, Australia.
  • Department of Hematology, Northern Pathology Victoria, Northern Health, Epping, Victoria, Australia.
  • Department of Medicine, Northern Health, University of Melbourne, Heidelberg, Victoria, Australia.
  • Department of Laboratory Medicine, National University Hospital, Singapore.
  • Department of Laboratory Medicine, Ng Teng Fong Hospital, Singapore.

ORCID-Profile: Hui Yin Lim

Zitieren

APA

Lim, H. Y., Yap, E. S., & Ho, P. (2026). Global Hemostasis Testing in Chronic Kidney Disease—Are They Better Predictors of Bleeding and Thrombosis Risk?. Seminars in Thrombosis and Hemostasis, 52(04), 391-404. https://doi.org/10.1055/s-0045-1809162

Vancouver

Lim HY, Yap ES, Ho P. Global Hemostasis Testing in Chronic Kidney Disease—Are They Better Predictors of Bleeding and Thrombosis Risk?. Seminars in Thrombosis and Hemostasis. 2026;52(04):391-404. doi:10.1055/s-0045-1809162

BibTeX
@article{Lim2026,
  author = {Lim, Hui Yin and Yap, Eng Soo and Ho, Prahlad},
  title = {Global Hemostasis Testing in Chronic Kidney Disease—Are They Better Predictors of Bleeding and Thrombosis Risk?},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  volume = {52},
  number = {04},
  pages = {391--404},
  doi = {10.1055/s-0045-1809162}
}
Kostenlos starten →